STOCK TITAN
  1. Home
  2. News
  3. ADMT

ADM TRONICS UNLTD INC - $ADMT STOCK NEWS

Welcome to our dedicated page for ADM TRONICS UNLTD news (Ticker: $ADMT), a resource for investors and traders seeking the latest updates and insights on ADM TRONICS UNLTD stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ADM TRONICS UNLTD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ADM TRONICS UNLTD's position in the market.

News
ADM Tronics Shareholder Video Conference Replay Available Now for Viewing Online with Update on Vet-Sonotron Veterinary Pain Treatment Technology
Rhea-AI Summary
ADM Tronics recently conducted a virtual Shareholder Video Conference to update shareholders on its Vet-Sonotron non-invasive veterinary therapeutic technology. The technology has shown positive efficacy in treating pain and inflammation in pets and other animals, with plans for a human medical version, the Sonotron, in development. The company aims to seek FDA clearance for the Sonotron to treat musculoskeletal pain conditions, potentially impacting shareholder valuations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
ADM Tronics to Host Shareholder Video Call on March 27 to Update Launch and Significance of Vet-Sonotron Veterinary Pain Treatment Device
Rhea-AI Summary
ADMT Tronics (ADMT) to Hold Shareholder Video Call on March 27, 2024, to Discuss Electronic Medical Device Innovations
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.67%
Tags
conferences
-
News
ADM Tronics CEO Presents Vet-Sonotron Veterinary Therapy Device at Medical Device Industry Webinar
Rhea-AI Summary
ADM Tronics CEO presents Vet-Sonotron non-invasive therapy device at MDG Premium webinar. The device offers innovative pain management solutions for small animals, showcasing significant efficacy in treating musculoskeletal conditions. The webinar highlighted the device's development, testing, and positive results, emphasizing its potential in veterinary care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
ADM Tronics’ Vet-Sonotron(R) Veterinary Pain Treatment Device Now in Production and Already Receiving Pre-Orders
Rhea-AI Summary
ADMT has completed R&D and production of its Vet-Sonotron non-invasive pain treatment device for the veterinary market. The device has shown remarkable results in treating musculoskeletal pain in animals. ADMT is currently manufacturing the initial batch of production units and has received pre-orders from the US and Southeast Asia. The company has also secured an agreement with a company providing leases for veterinary equipment. Vet-Sonotron is a significant advancement in veterinary medicine and ADMT plans to seek FDA clearance for the human medical market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Novel Therapeutic Technology Developed & Manufactured by ADM Tronics for Origin Life Sciences to Begin Clinical Study on Onychomycosis
Rhea-AI Summary
ADM Tronics (ADMT) announces client Origin Life Sciences, Inc. partnership
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.22%
Tags
clinical trial
-
News
ADM Tronics Prepares for Commercial Launch of Vet-Sonotron(R) Veterinary Therapy Device
Rhea-AI Summary
ADM Tronics (ADMT) is set to launch the Vet-Sonotron, a non-invasive veterinary therapy device, revolutionizing animal health care. The device offers a drug-free solution for pain treatment and is expected to tap into a $64 billion veterinary market in the US.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
none
News
ADM Tronics Reports First Quarter of Fiscal Year 2024 Results
Rhea-AI Summary
ADM Tronics Unlimited, Inc. announces results for its first fiscal quarter ended June 30, 2023. Revenues decreased by 17% due to supply chain challenges and timing of orders. Increased SG&A expenses and higher R&D expenses were also reported. The company is working to overcome supply shortages and anticipates increased revenues and higher margins with the launch of their Vet-Sonotron device.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
News
ADM Tronics Reports Fiscal Year 2023
Rhea-AI Summary
ADM Tronics Unlimited, Inc. announces increased revenues and reduced net loss for fiscal year 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
News
ADM Tronics Prepares for Launch of Vet-Sonotron(R) Novel Pain Treatment for Veterinary Market
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.33%
Tags
none
News
ADM Tronics Issues Shareholder Update Letter
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10%
Tags
none
Stock ADMT logo
ADM TRONICS UNLTD INC

OTC:ADMT

ADMT Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

ADMT Stock Data

5.41M
44.49%
Adhesive Manufacturing
Manufacturing
Link
United States of America
Northvale

About ADMT

adm tronics ("admt"​) specializes in electronic medical device design, development and manufacturing for diagnostic and therapeutic medical technologies at its fda-registered medical device manufacturing facility. admt is a one-stop source for complete design, engineering, regulatory and manufacturing services, specifically related to medical devices. its capability of bringing a medical device from the conceptual stage, through design, development and regulatory stages, into production, all in-house, differentiates admt from firms supplying only portions of those services. in addition to engineering, regulatory and manufacturing services for both partners and clients, admt has a number of proprietary medical devices. these devices, conceived, designed and produced in-house include therapeutic and diagnostic medical technologies in fields as diverse as audiology, physical medicine, wound therapy, neurology and urology. for more information visit the company’s websites - admtronics.com